CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.
Department of Pediatric Hepatology, Gastroenterology and Nutrition, Femme-Mère-Enfant Hospital, Hospices Civils de Lyon, Bron, France.
Autophagy. 2024 Aug;20(8):1837-1853. doi: 10.1080/15548627.2024.2338574. Epub 2024 Apr 18.
Crohn disease (CD) is an inflammatory bowel disease whose pathogenesis involves inappropriate immune responses toward gut microbiota on genetically predisposed backgrounds. Notably, CD is associated with single-nucleotide polymorphisms affecting several genes involved in macroautophagy/autophagy, the catabolic process that ensures the degradation and recycling of cytosolic components and microorganisms. In a clinical translation perspective, monitoring the autophagic activity of CD patients will require some knowledge on the intrinsic functional status of autophagy. Here, we focused on monocyte-derived dendritic cells (DCs) to characterize the intrinsic quantitative features of the autophagy flux. Starting with DCs from healthy donors, we documented a reprogramming of the steady state flux during the transition from the immature to mature status: both the autophagosome pool size and the flux were diminished at the mature stage while the autophagosome turnover remained stable. At the cohort level, DCs from CD patients were comparable to control in term of autophagy flux reprogramming capacity. However, the homozygous presence of (T300A) and polymorphisms abolished the capacity of CD patient DCs to reprogram their autophagy flux during maturation. This effect was not seen in the case of CD patients heterozygous for these polymorphisms, revealing a gene dose dependency effect. In contrast, the (R702W) polymorphism did not alter the flux reprogramming capacity of DCs. The data, opening new clinical translation perspectives, indicate that polymorphisms affecting autophagy-related genes can differentially influence the capacity of DCs to reprogram their steady state autophagy flux when exposed to proinflammatory challenges.: BAFA1: bafilomycin A1, CD: Crohn disease; DC: dendritic cells; HD: healthy donor; iDCs: immature DCs; IL: interleukin; J: autophagosome flux; LPS: lipopolysaccharide; MHC: major histocompatibility complex; nA: autophagosome pool size; SNPs: single-nucleotide polymorphisms; PCA: principal component analysis; TLR: toll like receptor; τ: transition time; TNF: tumor necrosis factor.
克罗恩病(CD)是一种炎症性肠病,其发病机制涉及在遗传易感性背景下对肠道微生物群产生不适当的免疫反应。值得注意的是,CD 与影响几个参与巨自噬/自噬的基因的单核苷酸多态性有关,自噬是一种分解代谢过程,可确保细胞溶质成分和微生物的降解和再循环。从临床转化的角度来看,监测 CD 患者的自噬活性需要了解自噬的内在功能状态。在这里,我们专注于单核细胞衍生的树突状细胞(DC)来描述自噬通量的内在定量特征。从健康供体的 DC 开始,我们记录了从未成熟到成熟状态的转变过程中稳态通量的重新编程:在成熟阶段,自噬体池大小和通量都减少,而自噬体周转率保持稳定。在队列水平上,CD 患者的 DC 在自噬通量重编程能力方面与对照组相当。然而,纯合存在 (T300A)和 多态性会消除 CD 患者 DC 在成熟过程中重新编程自噬通量的能力。在这些多态性杂合的 CD 患者中没有观察到这种影响,这表明存在基因剂量依赖性效应。相比之下, (R702W)多态性不会改变 DC 的通量重编程能力。这些数据为临床转化提供了新的视角,表明影响自噬相关基因的多态性可以在受到促炎挑战时,不同程度地影响 DC 重新编程其稳态自噬通量的能力。:BAFA1:巴弗洛霉素 A1;CD:克罗恩病;DC:树突状细胞;HD:健康供体;iDCs:未成熟 DCs;IL:白细胞介素;J:自噬体通量;LPS:脂多糖;MHC:主要组织相容性复合体;nA:自噬体池大小;SNP:单核苷酸多态性;PCA:主成分分析;TLR:Toll 样受体;τ:转换时间;TNF:肿瘤坏死因子。